Research Paper Volume 15, Issue 11 pp 4757—4773
Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway
Figure 1. NSUN5 expression and prognostic model prediction in ccRCC. (A) The expression of 12 m5C methylation regulators between tumor tissues and normal controls. (B, C) Expression and survival curve of NSUN5 in ccRCC. (D) Relationship between NSUN5 and various clinicopathological characteristics. (E) The mRNA expression of NSUN5 and prognosis of grade, stage, M and T. (F) The expression of NSUN5 in ccRCC cell lines and HK-2 cell line. (G) The protein expression of NSUN5 in ccRCC cell lines and HK-2 cell line. (H) The protein expression of NSUN5 in ccRCC tissue and paracancerous tissue (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001).